FIELD: medicine, pharmaceutics.
SUBSTANCE: there are presented 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one , (S)-3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and pharmaceutical compositions prepared with using said compound or its isomer, as well as the use thereof for preparing a therapeutic agent for preventing or treating inflammatory conditions, and a related method of treating. What is shown is the advantage of the compounds as related to the other broad spectrum chemokine inhibitors (BSCI) on anti-inflammatory activity; it possesses the pharmacokinetic, toxicological properties and the pharmaceutical safety parameters: (S)-3-(2',2'-dimethylpropanoylamino)-tetra-hydropyridin-2-one is 5-25 times more active than (R)-isomer.
EFFECT: higher anti-inflammatory activity.
13 cl, 10 dwg, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIINFLAMMATORY AGENTS | 2005 |
|
RU2410376C2 |
ANTIINFLAMMATORY MEDICATIONS | 2004 |
|
RU2365585C2 |
NEW GLUTAMINE CYCLASE INHIBITOR AND ITS APPLICATION | 2018 |
|
RU2791703C2 |
NEW INHIBITOR OF GLUTAMINYL CYCLASE AND ITS USE | 2017 |
|
RU2665633C1 |
NEW INHIBITOR OF GLUTAMINYL CYCLASE AND ITS USE FOR TREATMENT OF LUNG AND RESPIRATORY DISEASES | 2017 |
|
RU2662559C1 |
LIGANDS FOR G-PROTEIN CONJUGATED RECEPTOR | 2005 |
|
RU2454416C2 |
COMPOSITION FOR MODULATION OF CELL ADHESION MOLECULE EXPRESSION | 2007 |
|
RU2503463C2 |
PIPERAZINE INDOLES AS OXYTOCIN RECEPTOR ANTAGONISTS | 2005 |
|
RU2382038C2 |
LIGANDS FOR G-PROTEIN COUPLED RECEPTORS | 2006 |
|
RU2471022C2 |
COMPOUNDS SHOWING CRTH2 ANTAGONIST ACTIVITY | 2007 |
|
RU2458918C2 |
Authors
Dates
2013-06-10—Published
2008-08-01—Filed